Association between angiotensin-converting enzyme insertion/deletion polymorphism and migraine: a meta-analysis

References

• Yu S, Liu R, Zhao G, et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 2012;52(4):582–91.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2163–96.
   PubMed Web of Science ®Google Scholar
• Mulder EJ, Van Baal C, Gaist D, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 2003;6(5):422–31.
   PubMedGoogle Scholar
• de Vries B, Frants RR, Ferrari MD, et al. Molecular genetics of migraine. Hum Genet 2009;126(1):115–32.
   PubMed Web of Science ®Google Scholar
• Nandha R, Singh H. Renin angiotensin system: a novel target for migraine prophylaxis. Indian J Pharmacol 2012;44(2):157–60.
   PubMed Web of Science ®Google Scholar
• Stovner LJ. Migraine prophylaxis with drugs influencing the renin-angiotensin system. Eur J Neurol 2007;14(7):713–4.
   PubMed Web of Science ®Google Scholar
• Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51(1):197–205.
   PubMed Web of Science ®Google Scholar
• An X-K, Lu C-X, Ma Q-L, et al. Association of MTHFR C677T polymorphism with susceptibility to migraine in the Chinese population. Neurosci Lett 2013;549:78–81.
   PubMed Web of Science ®Google Scholar
• Fusayasu E, Kowa H, Takeshima T, et al. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 2007;128(3):209–14.
   PubMed Web of Science ®Google Scholar
• Gales BJ, Bailey EK, Reed AN, Gales MA. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines. Ann Pharmacother 2010;44(2):360–6.
   PubMed Web of Science ®Google Scholar
• Paterna S, Di Pasquale P, D’Angelo A, et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000;43(3):133–6.
   PubMed Web of Science ®Google Scholar
• Cakmak EA, Cataloluk O, Yoldas T, et al. Migraine and angiotensin-converting enzyme association in Turkish patients. Pain Clinic 2003;15(4):473–7.
   Web of Science ®Google Scholar
• Kowa H, Fusayasu E, Ijiri T, et al. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 2005;374(2):129–31.
   PubMed Web of Science ®Google Scholar
• Lea RA, Ovcaric M, Sundholm J, et al. Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 2005;136(1–2):112–7.
   PubMedGoogle Scholar
• Lin JJ, Wang PJ, Chen CH, et al. Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol Taiwan 2005;14(3):120–5.
   PubMedGoogle Scholar
• Kara I, Ozkok E, Aydin M, et al. Combined effects of ACE and MMP-3 polymorphisms on migraine development. Cephalalgia 2007;27(3):235–43.
   PubMed Web of Science ®Google Scholar
• Tronvik E, Stovner LJ, Bovim G, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol 2008;8:4.
   PubMed Web of Science ®Google Scholar
• Joshi G, Pradhan S, Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J Neurol Sci 2009;277(1–2):133–7.
   PubMed Web of Science ®Google Scholar
• Schuerks M, Zee RYL, Buring JE, et al. ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology 2009;72(7):650–6.
   PubMed Web of Science ®Google Scholar
• Ozbey U, Etem E, Ozel S, et al. Is there a relation between insertion/deletion polymorphism of the angiotensin converting enzyme gene in patients of migraine with aura and migraine without aura in region of eastern Turkey? Turkiye Klinikleri J Med Sci 2010;30(2):502–6.
   Web of Science ®Google Scholar
• Horasanli B, Atac FB, Coven I, et al. Angiotensin I-converting enzyme gene (I/D) polymorphism in patients with migraine. Headache 2013;53(1):161–4.
   PubMed Web of Science ®Google Scholar
• Sipahi T, Guldiken B, Kabayel L, et al. Endothelial nitric oxide synthase and angiotensin converting enzyme gene polymorphisms in migraine patients. Arch Neuropsychiatr 2013;50(3):274–8.
   Web of Science ®Google Scholar
• Palmirotta R, Barbanti P, Ludovici G, et al. Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study. Pharmacogenomics 2014;15(2):147–55.
   PubMed Web of Science ®Google Scholar
• Schuerks M, Rist PM, Kurth T. MTHFR 677C > T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache 2010;50(4):588–99.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557–60.
   PubMed Web of Science ®Google Scholar
• Tietjen GE, Herial NA, Utley C, et al. Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia 2009;29(9):960–8.
   PubMed Web of Science ®Google Scholar
• Pizza V, Bisogno A, Lamaida E, et al. Migraine and coronary artery disease: an open study on the genetic polymorphism of the 5, 10 methylenetetrahydrofolate (MTHFR) and angiotensin I-converting enzyme (ACE) genes. Cent Nerv Syst Agents Med Chem 2010;10(2):91–6.
   PubMedGoogle Scholar
• Pizza V, Infante F, Agresta A, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in migraine patients. Pharmacologyonline 2013;2:19–22.
   Google Scholar
• Pizza V, Infante F, Agresta A,et al. The role of angiotensin-converting enzyme gene in migraine patients. Curr Neurobiol 2013;4(1-2):85–8.
   Google Scholar
• Schuerks M, Zee RYL, Buring JE, et al. MTHFR 677C -> T and ACE D/I polymorphisms and migraine attack frequency in women. Cephalalgia 2010;30(4):447–56.
   PubMed Web of Science ®Google Scholar
• Kurth T. Migraine and ischaemic vascular events. Cephalalgia 2007;27(8):965–75.
   PubMedGoogle Scholar
• Dalkara T, Nozari A, Moskowitz MA. Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol 2010;9(3):309–17.
   PubMed Web of Science ®Google Scholar
• Anttila V, Stefansson H, Kallela M, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 2010;42(10):869–73.
   PubMed Web of Science ®Google Scholar
• Chasman DI, Schuerks M, Anttila V, et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 2011;43(7):695–8.
   PubMed Web of Science ®Google Scholar
• Freilinger T, Anttila V, de Vries B, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 2012;44(7):777–82.
   PubMed Web of Science ®Google Scholar
• Ripa P, Ornello R, Pistoia F, et al. The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis. Expert Rev Neurother 2014;14(9):1043–55.
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86(4):1343–6.
   PubMed Web of Science ®Google Scholar
• Zill P, Baghai TC, Schule C, et al. DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression. PLoS One 2012;7(7):e40479.
   PubMed Web of Science ®Google Scholar